After bringing the global economy to a grinding halt, the coronavirus pandemic is subsiding in most regions, thanks to the mass production
For pharmaceutical companies, 2020 was a busy year when the healthcare sector went into overdrive to deal with the challenges posed by
Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q1 2021 earnings call dated May. 14, 2021 Corporate Participants: Will O'Connor -- Investor Relations, Stern Investor Relations, Inc.
Earlier this week, biotech company ImmunoGen (NASDAQ: IMGN) reported mixed financial results for the first quarter of 2021, pushing the stock into
Veru Inc. (NASDAQ: VERU) Q2 2021 earnings call dated May. 12, 2021 Corporate Participants: Sam Fisch -- Director of Investor Relations Mitchell Steiner -- Chairman, President,
FibroGen Inc. (NASDAQ: FGEN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Michael Tung -- Vice President of Corporate Strategy and Investor
Immunogen, Inc. (NASDAQ: IMGN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications and Investor
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q1 2021 earnings call dated May. 06, 2021 Corporate Participants: Justin Holko -- Vice President, Investor Relations Leonard S.
Shares of Moderna Inc. (NASDAQ: MRNA) were down 3% in morning hours on Thursday despite the company reporting the first profitable quarter
After being hit by the virus-induced slowdown in store footfall initially, CVS Health Corporation (NYSE: CVS) has regained the lost momentum by
AbbVie Inc. (NYSE: ABBV) has long been fighting to delay the entry of generic alternatives to Humira, the pharma giant's flagship product
Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Traci McCarty -- Vice President of Investor Relations Jean-Jacques
Bristol-Myers Squibb Company (NYSE: BMY) reported first quarter 2021 earnings results today. Revenues increased 3% year-over-year to $11.1 billion. Net earnings attributable
Biogen Inc. (NASDAQ: BIIB) reported first quarter 2021 earnings results today. Total revenues decreased 24% year-over-year to $2.6 billion. On a constant
After dominating the cystic fibrosis market for quite some time, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is currently expanding its clinical programs to
The growing demand for new therapeutic solutions and advanced research in areas like human-genome will keep the biotechnology industry busy in the
The coronavirus outbreak has made leading pharma companies channelize their resources for vaccine development, and the efforts have been largely successful. While
While rising interest in biotechnology has provided a much-needed fillip to the research and development of therapies, one major hurdle stops them
Entera Bio Ltd. (NASDAQ: ENTX) Q4 2020 earnings call dated Mar. 18, 2021 Corporate Participants: Jonathan Lieber -- Chief Financial Officer, U.S.
Avid Bioservices, Inc. (NASDAQ: CDMO) Q3 2021 earnings call dated Mar. 08, 2021 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President and Chief
Shares of Moderna Inc. (NASDAQ: MRNA) were up 6% in morning trade on Thursday after the company reported its fourth quarter and